Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
CUV:ASX
Clinuvel Pharmaceuticals Ltd
9,17 A$
+0,55%
(+0,050) 1D
1 may, 16:10:09 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CUV...
Açın
9,20 A$
High
9,37 A$
Low
9,04 A$
Mkt. cap
462,42 mln
Avg. vol.
102,66K
Volume
49,83K
Dividend
0,55%
Quarterly dividend
0,01 A$
Ex dividend date
4 sen 2025
P/E ratio
14,24
52-wk high
14,00 A$
52-wk low
8,57 A$
EPS
0,64 A$
Shares outstanding
50,43 mln
No. of employees
16
News stories
From sources across the web
About Clinuvel Pharmaceuticals Ltd
CEO-
Employees16
Founded1999
Headquarters-
Sector-
Websiteclinuvel.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
29,68 mln
29,68 mln
18,47 mln
18,47 mln
Cost of goods sold
2,71 mln
2,71 mln
2,28 mln
2,28 mln
Cost of revenue
2,71 mln
2,71 mln
2,28 mln
2,28 mln
Research and development expenses
2,28 mln
2,28 mln
1,70 mln
1,70 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,18 mln
9,18 mln
6,96 mln
6,96 mln
Operating expense
12,23 mln
12,23 mln
9,42 mln
9,42 mln
Total operating expenses
14,94 mln
14,94 mln
11,71 mln
11,71 mln
Operating income
14,74 mln
14,74 mln
6,76 mln
6,76 mln
Other non operating income
-
-
-
-
EBT including unusual items
14,81 mln
14,81 mln
7,29 mln
7,29 mln
EBT excluding unusual items
14,81 mln
14,81 mln
7,29 mln
7,29 mln
Income tax expense
3,76 mln
3,76 mln
2,07 mln
2,07 mln
Effective tax rate
25,40%
25,40%
28,39%
28,39%
Other operating expenses
-12,09K
-12,09K
-1,24K
-1,24K
Net income
11,05 mln
11,05 mln
5,22 mln
5,22 mln
Net profit margin
37,22%
37,22%
28,28%
28,28%
Earnings per share
-
-
-
-
Interest and investment income
2,41 mln
2,41 mln
2,63 mln
2,63 mln
Interest expense
-1,24 mln
-1,24 mln
-1,28 mln
-1,28 mln
Net interest expenses
1,16 mln
1,16 mln
1,35 mln
1,35 mln
Depreciation and amortization charges
286,78K
286,78K
250,02K
250,02K
EBITDA
14,83 mln
14,83 mln
7,01 mln
7,01 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer